Biodesix Inc (BDSX)

NASDAQ
Currency in USD
0.793
-0.037(-4.47%)
Real-time Data
BDSX Scorecard
Full Analysis
Quickly burning through cash
Fair Value
Day's Range
0.7880.831
52 wk Range
0.6352.040
Key Statistics
Edit
Prev. Close
0.831
Open
0.82
Day's Range
0.788-0.831
52 wk Range
0.635-2.04
Volume
70.58K
Average Vol. (3m)
432.31K
1-Year Change
-39.78%
Book Value / Share
0.14
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
BDSX Scorecardpro icon
Company’s Health
pro lockUnlock
Fair Value
pro lockUnlock Price
Fair Pricepro lock
Upsidepro lock
Price Target
3.100
Upside
+290.92%
Members' Sentiments
Bearish
Bullish
ProTips
Significant return over the last week
Show more

Biodesix Inc Company Profile

Biodesix, Inc. operates as a data-driven diagnostic solutions company in the United States. The company offers blood-based lung tests, including Nodify XL2 and Nodify CDT tests, together marketed as part of Nodify Lung Nodule Risk Assessment testing strategy, to assess the risk of lung cancer and help in identifying the appropriate treatment pathway and help physicians in reclassifying risk of malignancy in patients with suspicious lung nodules. It also provides GeneStrat ddPCR and NGS, and VeriStrat tests, which are used in the diagnosis of lung cancer to measure the presence of mutations in the tumor and the state of the patient’s immune system to establish the patient’s prognosis and help guide treatment decisions. In addition, the company, through its partnership with Bio-Rad Laboratories, Inc., provides Bio-Rad SARS-CoV-2 ddPCR, a COVID-19 Test under Biodesix WorkSafe testing program; and Platelia SARS-CoV-2 Total Ab test, an antibody test for detecting a B-cell immune response to SARS-CoV-2 that indicate recent or prior infection. Further, it offers diagnostic and clinical research, as well as clinical trial testing services to biopharmaceutical companies; and discovers, develops, and commercializes companion diagnostics. The company was formerly known as Elston Technologies, Inc. and as changed to Biodesix, Inc. in 2006. Biodesix, Inc. was incorporated in 2005 and is headquartered in Louisville, Colorado.

Biodesix Inc Earnings Call Summary for Q4/2024

  • Q4 revenue of $20.4M exceeded forecasts, up 39% YoY; EPS of -$0.06 beat expectations
  • Stock surged 19.21% after-hours; analysts maintain Strong Buy consensus with $3.00-$3.50 price targets
  • Full-year 2024 revenue reached $71.3M, up 45%; gross margins improved to 78.2%
  • 2025 revenue guidance set at $92-95M; adjusted EBITDA profitability expected in H2 2025
  • Company expanding sales force and engaging primary care physicians to drive growth
Last Updated: 03/03/2025, 05:23 PM
Read Full Transcript

Compare BDSX to Peers and Sector

Metrics to compare
BDSX
Peers
Sector
Relationship
P/E Ratio
−2.7x−3.4x−0.5x
PEG Ratio
−0.06−0.060.00
Price / Book
5.6x0.5x2.6x
Price / LTM Sales
1.6x0.9x3.0x
Upside (Analyst Target)
261.0%71.1%54.7%
Fair Value Upside
Unlock−7.2%9.3%Unlock

Analyst Ratings

6 Buy
0 Hold
0 Sell
Ratings:
6 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 3.100
(+290.92% Upside)

Earnings

Latest Release
Mar 03, 2025
EPS / Forecast
-0.06 / -0.07
Revenue / Forecast
20.42M / 19.87M
EPS Revisions
Last 90 days

People Also Watch

0.1488
NKGN
-9.87%
0.065
AGMH
-7.43%
4.190
REBN
+3.46%
28.92
TBRG
-1.43%
1.55
PLRX
-2.52%

FAQ

What Is the Biodesix (BDSX) Stock Price Today?

The Biodesix stock price today is 0.793

What Stock Exchange Does Biodesix Trade On?

Biodesix is listed and trades on the NASDAQ stock exchange.

What Is the Stock Symbol for Biodesix?

The stock symbol for Biodesix is "BDSX."

What Is the Biodesix Market Cap?

As of today, Biodesix market cap is 117.37M.

What is Biodesix Earnings Per Share?

The Biodesix EPS is -0.331.

What Is the Next Biodesix Earnings Date?

Biodesix will release its next earnings report on May 07, 2025.

From a Technical Analysis Perspective, Is BDSX a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.